Searched for
LAL PATHLABS
Sunil Singhania-backed Abakkus Small Cap Fund adds 3 new stocks, increases stake in HDFC Bank, SBI and 49 othersSunil Singhania's Abakkus Small Cap Fund added three new stocks in May, including Tanla Platforms and Intellect Design Arena. The fund also...- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Smallcaps continue to draw domestic flows, stock selection key: Sandip SabharwalIndian equity markets show resilience post-election results. Market expert Sandip Sabharwal notes that governance and policy continuity are...
- Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswingFive stocks from the Nifty500 universe were flagged in the RSI Trending Up scan on May 4 after gaining over 4%. The indicator turned positi...
- Positive Breakout: These 14 stocks cross above their 200 DMAsAs long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend.
- Forget the noise: These 54 smallcap stocks attracted FII buying in March quarterForeign institutional investors are strategically buying into beaten-down smallcap stocks in India, increasing stakes in 54 companies despi...
- Add Dr Lal Pathlabs, target price Rs 2,910: HDFC SecuritiesHDFC Securities has an 'add' call on Dr Lal Pathlabs with a target price of Rs 2910. The company reported a total income of Rs 621.80 crore...
- JM Financial upgrades Dr Lal Pathlabs to Buy, target price Rs 3,600JM Financial recommends buying Dr. Lal Pathlabs with a target price of Rs 3,600, citing a potential 25% upside. The company's Q3 earnings s...
- Buy Dr. Lal Pathlabs, target price Rs 3181: BNP Paribas SecuritiesDr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 19103.91 Crore) operating in Hospital...
- Dr Lal PathLabs Q1 Results: Net profit dips 57% to Rs 58 croreThe company had reported a net profit of Rs 134 crore in the April-June period of the last fiscal.Revenue from operations declined to Rs 50...
- Buy Dr. Lal Pathlabs, target price Rs 2981: ICICI SecuritiesDr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 16941.69 Crore) operating in Hospital...
- Buy Dr. Lal Pathlabs, target price Rs 2850: IIFLDr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 23223.22 Crore) operating in Hospital...
- Buy Dr. Lal Pathlabs, target price Rs 3525: ICICI SecuritiesDr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 23488.67 Crore) operating in Hospital...
- Dr Lal PathLabs Q1 results: Net profit declines 52% to Rs 28.4 croreThe company had posted a net profit of Rs 59.1 crore for the corresponding period of the previous fiscal, Dr Lal PathLabs said in a filing ...
- Buy Dr. Lal Pathlabs, target Rs 1,249: Dharmesh ShahBuy Dr. Lal Pathlabs Ltd. at a price target of Rs 1249.0 and a stoploss at Rs 1136 from entry point.
- Buy Dr Lal Pathlabs, target Rs 1,235: Dharmesh ShahBuy Dr. Lal Pathlabs Ltd. at a price target of Rs 1235.0 and a stoploss at Rs 1148 from entry point.
- CLSA maintains 'buy' on Dr Lal PathLabsDr Lal PathLabs' volume growth in the past two quarters has been encouraging.
- Buy Dr. Lal Pathlabs, target Rs 900: Edelweiss Financial ServicesBuy Dr. Lal Pathlabs at a price target of Rs 900. Time period given by analyst is a year when Dr. Lal Pathlabs price can reach defined targ...
- Nomura upgrades Dr Lal PathLabs to 'buy' from 'neutral'The brokerage said growth in recent times in Dr Lal PathLabs has been hit by demonetisation but it remains constructive on long term growth...
- TA Associates buys minority stake in Lal PathLabsTA Associates made a minority investment in Dr Lal PathLabs by purchasing half of Sequoia Capital’s stake in the company for an undisclosed...
Load More
